BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Innova Biosciences Continues to Experience Growth in Tough Economic Climate


4/22/2009 2:48:38 PM

The current financial and economic climate has made it difficult for mid-stage companies to grow and succeed – currently the norm at the moment is to experience contraction.

However, one company which is bucking that trend is Innova Biosciences, which continues to experience great success with its range of Lightning-Link™ bioconjugation kits. The end products of the kits – conjugates, are used in diagnostic tests in hospitals and research labs around the world and in consumer items such as pregnancy test kits.

Global sales, from USA through to Europe and Asia Pacific, continue to grow strongly, which has been achieved through the recent development of an international distribution network and an effective PR campaign. For instance, Innova Biosciences produced a video to demonstrate the benefits of the technology to the scientific community.

As a result of increased demand for its product range, Innova Biosciences recently created several new positions within the organisation. This success comes just after the company was awarded, as part of a consortium, an EU grant to develop a platform for biomarker discovery.

Commenting on the continued success of Innova Biosciences, Nick Gee (CEO):

‘In the current economic climate it is refreshing to see the business undergoing organic growth, which has been generated through robust strategic planning and the hard work of the Innova Biosciences’ team.’

About the company: Innova Biosciences is a growing, dynamic business, based in Cambridge, UK. At the core of Innova’s business is the Lightning-Link™, an innovative technology that simplifies production of bioconjugates for use in R&D applications, drug discovery and diagnostics. The expanding Lightning-Link™ portfolio currently consists of over 40 products and is sold to research laboratories in over 30 countries around the world.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES